©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Jun 20, 2025; 15(2): 101430
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.101430
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.101430
Fecal microbiota transplantation in allergic diseases
Ece Tüsüz Önata, Öner Özdemir, Division of Pediatric Allergy and Immunology, Medical Faculty, Sakarya University, Adapazarı 54100, Sakarya, Türkiye
Author contributions: Tüsüz Önata E and Özdemir Ö performed the research, wrote the article. All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Öner Özdemir, MD, Professor, Division of Pediatric Allergy and Immunology, Medical Faculty, Sakarya University, Adnan Menderes cad, Adapazarı 54100, Sakarya, Türkiye. ozdemir_oner@hotmail.com
Received: September 13, 2024
Revised: October 17, 2024
Accepted: November 1, 2024
Published online: June 20, 2025
Processing time: 74 Days and 15.1 Hours
Revised: October 17, 2024
Accepted: November 1, 2024
Published online: June 20, 2025
Processing time: 74 Days and 15.1 Hours
Core Tip
Core Tip: Fecal microbiota transplantation (FMT) studies have gained popularity after probiotic, prebiotic, symbiotic studies in the treatment of dysbiosis and related diseases. FMT is the process of transferring faeces from a healthy donor to another recipient in order to restore the gut microbiota and provide a therapeutic benefit.